SCHEMBL7820175

SCHEMBL7820175

COc1ccc2nc(Cl)c3c(c2c1)-c1ccccc1C3=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.51
C1R P00736 1/20 0.47
MAPT P10636 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PDE4B Q07343 2/20 0.46
PDE4D Q08499 2/20 0.46
KDM4E B2RXH2 5/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
BCHE P06276 2/20 0.45
ACHE P22303 2/20 0.45
HSD17B10 Q99714 2/20 0.44
LMNA P02545 2/20 0.44
ALDH1A1 P00352 3/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7825423 0.90 TP53 (0.51) TP53MAPTTDP1MAPK1L3MBTL1
SCHEMBL7822017 0.86 NTRK1 (0.51) L3MBTL1PDE4BPDE4DKDM4EMEN1
SCHEMBL7811355 0.86 NTRK1 (0.50) TP53PDE4BPDE4DKDM4EMEN1
SCHEMBL7820606 0.84 MEN1 (0.49) MAPTTDP1MAPK1KDM4ESMN1; SMN2
SCHEMBL7818201 0.82 KDM4E (0.46) C1RMAPK1L3MBTL1KDM4ESMN1; SMN2
SCHEMBL7464639 0.81 TP53 (0.60) TP53C1RMAPTTDP1MAPK1
SCHEMBL3736581 0.81 NTRK1 (0.51) L3MBTL1PDE4BPDE4DKDM4EMEN1
SCHEMBL7820788 0.80 USP8 (0.42) TP53L3MBTL1KDM4ESMN1; SMN2KMT2A
SCHEMBL6516391 0.80 PDE4B (0.43) MAPTPDE4BSMN1; SMN2MEN1KMT2A
SCHEMBL12781496 0.78 PABPC1 (0.47) C1RMAPTTDP1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0713870-B1 NOVEL FUSED INDAN DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2001-07-18 EP disclosed
US-6028079-A FOR TREATING TUMOR OF MAMMAL TAIHO PHARMACEUTICAL CO., LTD (JP) 2000-02-22 US disclosed
US-5733918-A ANTITUMOR AGENT TAIHO PHARMACEUTICAL CO., LTD. (JP) 1998-03-31 US disclosed
US-5710162-A ANTITUMOR AGENTS TAIHO PHARMACEUTICAL CO., LTD. (JP) 1998-01-20 US disclosed
EP-0713870-A1 NOVEL FUSED INDAN DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF TAIHO PHARMACEUTICAL CO., LTD. (JP) 1996-05-29 EP disclosed